Cancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiative.
Cancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiative.
复制标题
“一带一路”成员国癌症发病率、死亡率及危险因素分析。
DOI：
10.1186/s12885-022-09657-3
复制
发表时间：
2022-05-25
期刊：
影响因子：
3.8
通讯作者：
中科院分区：
文献类型：
--
作者：
目前，“一带一路”成员国（约占世界人口的61.78%）不同程度地面临着不同类型的癌症威胁。我们对“一带一路”沿线国家癌症发病率、死亡率及危险因素进行分析，探讨各国之间健康医疗合作的基础，为制定构建健康“一带一路”的癌症防控政策提供依据。数据来源于 2020 年全球癌症观察站和癌症国家概况。发病率和死亡率为年龄标准化率 (ASR)。采用人口归因分数（PAF）来衡量“一带一路”国家癌症的危险因素。死亡率与发病率（MIR）的计算方法是将死亡率除以发病率。该研究总共包括 26 种癌症。肺癌、乳腺癌、结直肠癌、胃癌、肝癌、前列腺癌、宫颈癌、食管癌、甲状腺癌和子宫癌是“一带一路”沿线国家最常见且年龄标准化死亡率最高的癌症。对于男性来说，匈牙利的癌症年龄标准化发病率和死亡率最高（ASR，分别为每 100,000 人 289.3 例，ASR，每 100,000 人 235.7 例），其次是拉脱维亚（ASR，每 100,000 人 288.6 例，ASR，每 100,000 人 196.5 例）。在女性中，估计发病率最高的是希腊（ASR，每 100,000 人 238.7 例），死亡率最高的是文莱（ASR，每 100,000 人 192.3 例）。所有国家均处于中高人类发展指数范围，其中约一半（46.88%）的国家实现高人类发展指数，主要集中在中东欧（13 个国家）和西亚（10 个国家）。阿拉伯联合酋长国的男性和女性 MIR 最高（1.59 vs 2.19）。烟草制品、感染因素和紫外线是“一带一路”国家的三大癌症危险因素。 “一带一路”沿线国家癌症总体负担仍然较大，相应的癌症防治政策有待完善。加强成员国之间的卫生合作将有助于共同应对癌症风险和挑战。在线版本包含可在 10.1186/s12885-022-09657-3 获取的补充材料。
At present, “Belt and Road” (“B&R”) member states (accounting for about 61.78% of the world’s population) face different types of cancer threats to varying degrees. We analyzed the incidence and mortality and risk factors of cancer in the member countries of the “B&R” to explore the basis of health and medical cooperation between countries and provide a foundation for formulating cancer prevention and control policies for building a healthy "B&R." Data were derived from the Global Cancer Observatory and Cancer Country Profiles in 2020. Incidence and mortality were age-standardized rates (ASRs). Population attributable fractions (PAFs) was applied to measure risk factors of cancers in the “B&R” countries. The mortalitytoincidence ratio (MIR) was calculated by dividing the mortality rate by the incidence rate. A total of 26 cancers were included in the study. Lung, breast, colorectal, stomach, liver, prostate, cervical, esophageal, thyroid, and uterine cancers were the most common and highest in age-standardized mortality in the “B&R” countries. For men, Hungary had the highest cancer age-standardized incidence and mortality (ASR, 289.3 per 100,000 and ASR, 235.7 per 100,000, respectively), followed by Latvia (ASR, 288.6 per 100,000 and ASR, 196.5 per 100,000, respectively). In females, the highest incidence rates were estimated in Greece (ASR, 238.7 per 100,000), and the highest mortality rate was Brunei (ASR, 192.3 per 100,000). All countries were in the middle or high HDI range, with about half (46.88%) of countries achieving high HDI, mostly in Central and Eastern Europe (13 countries) and West Asia (10 countries). The United Arab Emirates had the highest MIR in male and female (1.59 vs 2.19). Tobacco products, infectious factors, and ultraviolet rays were the three main cancer risk factors in the “B&R” countries. The overall burden of cancer in the countries along the “B&R” remains substantial, while the corresponding cancer prevention and control policies need to be improved. Strengthening health cooperation among member countries will contribute to a joint response to the risks and challenges posed by cancer. The online version contains supplementary material available at 10.1186/s12885-022-09657-3.